Exp Clin Endocrinol Diabetes 2007; 115(10): 641-646
DOI: 10.1055/s-2007-982500
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Long-term Effects of Terminalia chebula Retz. on Hyperglycemia and Associated Hyperlipidemia, Tissue Glycogen Content and in Vitro Release of Insulin in Streptozotocin Induced Diabetic Rats

Y. K. Murali 1 , 2 , P. Anand 1 , V. Tandon 1 , R. Singh 2 , R. Chandra 1 , P. S. Murthy 1
  • 1Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India
  • 2Institute of Biomedical Sciences, Bundelkhand University, Jhansi, UP, India
Weitere Informationen

Publikationsverlauf

received 19.03.2007 first decision 14.05.2007

accepted 23.05.2007

Publikationsdatum:
30. November 2007 (online)

Preview

Abstract

The aqueous extract of the fruits of Terminalia chebula Retz. has been evaluated for its antidiabetic activity in streptozotocin (STZ) induced mild diabetic rats and compared with a known drug, tolbutamide. The oral effective dose (ED) of the extract was observed to be 200 mg/kg body weight, which produced a fall of 55.6% (p<0.01) in the oral glucose tolerance test. Oral administration of ED of aqueous extract of T.chebula (AETC) daily once for two months reduced the elevated blood glucose by 43.2% (p<0.01) and significantly reduced the increase in glycosylated hemoglobin (HbA1c) (p<0.01). The same dose also showed a marked improvement in controlling the elevated blood lipids as well as decreased serum insulin levels in contrast to the untreated diabetic animals. Hepatic and skeletal muscle glycogen content decreased by 75% and 62.9% respectively in diabetic controls, these alterations were partly prevented (34.9% and 21.17%) in AETC treated group when compared to the healthy controls. The in vitro studies with pancreatic islets showed that the insulin release was nearly two times more than that in untreated diabetic animals. The treatment did not have any unfavorable effect on other blood parameters of liver and kidney function tests. LD 50 was found to be above 3 g/kg bw i.e. 15 times of ED, because there were no deaths of animals even at this dose indicating high margin of safety. These findings suggest further investigations for the possible use of the aqueous extract of fruits of T.chebula for the treatment of diabetes.

References

Correspondence

Prof. R. Chandra
Prof. P.S. Murthy

Dr. B.R. Ambedkar Center for Biomedical Research

University of Delhi

110007 Delhi

India

Telefon: +91/11/2766 62 72, 2766 71 51

Fax: +91/11/2766 62 48

eMail: acbrdu@hotmail.com

eMail: psmurthy_2000@yahoo.com